Rogue antibodies could be driving severe COVID-19

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Yu Zuo, Shanea K. Estes, Ramadan A. Ali et al. · Science Translational Medicine · 2020 · 644 citations · Full text

Life Sciences, Hematology, Immunology +16

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear et al. · The Lancet Respiratory Medicine · 2020 · 455 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Diverse Functional Autoantibodies in Patients with COVID-19

Eric Y. Wang, Tianyang Mao, Jon Klein et al. · medRxiv · 2020 · 205 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

Anthony Gordon, Paul Mouncey, Farah Al-Beidh et al. · medRxiv · 2021 · 137 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12